ERBB2 and breast carcinoma: Further support for the involvement of HER2 in the initiation and progression of breast cancer comes from analysis of transgenic mice generated by targeting overexpression of activated neu (the rat homolog of HER2) to the mammary gland under the control of the murine mammary tumor virus (MMTV) promoter [2].